Atlas Trials

A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood

Clinical trial NCT00001317 · COMPLETED

Trial details

NCT number
NCT00001317
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Granulomatous Disease
Start date
1992-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.